학술논문

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
Document Type
Article
Source
In Annals of Oncology November 2017 28(11):2813-2819
Subject
Language
ISSN
0923-7534